for the Health Professions, 7e 7th Edition
,Table Of Contents
Section I: Pathophysiology: Background and Overview
1. Introduction to Pathophysiology
2. Fluid, Electrolyte, and Acid-Base Imbalances
3. Introduction to Basic Pharmacology and Other Common Therapies
4. Pain
Section II: Defense/Protective
5. Inflammation and Healing
6. Infection
7. Immunity
Section III: Pathophysiology of Body Systems
8. Skin Disorders
9. Musculoskeletal Disorders
10. Blood and the Circulatory System
11. Lymphatic System Disorders
12. Cardiovascular System Disorders
13. Respiratory System Disorders
14. Neurological Disorders
15. Eyes, Ears and Other Sensory Organs
16. Endocrine Disorders
17. Digestive System Disorders
18. Urinary System Disorders
19. Reproductive System Disorders
20. Neoplasms and Cancer
Section IV: Factors Contributing to Pathophysiology
21. Congenital and Genetic Disorders
22. Complications Due to Pregnancy
23. Complications Due to Adolescence
24. Complications Due to Aging
Section V: Environmental Factors and Pathophysiology
25. Immobility and Associated Problems
26. Stress and Associated Problems
27. Substance Abuse and Associated Problems
28. Environmental Hazards and Associated Problems
, 01: Introduction to
Pathophysiology
Q. A collection of signs and symptoms, often affecting more than one organ or system, that usually
occur together in response to a certain condition is referred to as a (an):
a. acute disease.
b. multiorgan disorder.
c. syndrome.
d. manifestation.
ANS: C REF: 7
Q. All of the following statements are correct about cell damage EXCEPT:
a. The initial stage of cell damage often causes an alteration in metabolic reactions.
b. If the factor causing the damage is removed quickly, the cell may be able to recover and return to its nor
c. If the noxious factor remains for an extended period of time, the damage becomes irreversible and the ce
d. Initially, cell damage does not change cell metabolism, structure, or function.
ANS: D REF: 9
Q. Which of the following conditions distinguishes double blind studies used in health research?
Neither the members of the control group or the experimental group nor the person administering the trea
a. receiving the experimental therapy.
b. Both groups of research subjects and the person administering the treatment know who is receiving the ex
The research subjects do not know, but the person administering the treatment knows who is receiving pla
c. therapy.
d. Only members of the control group know they are receiving standard therapy.
ANS: A REF: 3 | 4
, Q. If the data collected from the research process confirm that the new treatment has increased
effectiveness and is safe, this is called:
a. the placebo effect.
b. evidence-based research.
c. blind research studies.
d. approval for immediate distribution.
ANS: B REF: 4
28. A short-term illness that develops very quickly with perhaps a high fever or severe pain is called:
a. acute.
b. latent.
c. chronic.
d. manifestation.
ANS: A REF: 6
Q. The term prognosis refers to the:
a. period of recovery and return to a normal state.
b. expected outcome of the disease.
c. mortality and morbidity rates for a given population.
d. typical collection of signs and symptoms.
ANS: B REF: 7